Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells

Frontiers in Oncology

Volumn 4 JUL, Issue , 2014, Pages

  Carpenter, Erica L ^a   Rader, JulieAnn ^b   Ruden, Jacob ^b   Rappaport, Eric F ^b   Hunter, Kristen N ^b   Hallberg, Paul L ^a   Krytska, Kate ^b   O'Dwyer, Peter J ^a   Mosse, Yael P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Circulating tumor cell; Disseminated tumor cell; Neuroblastoma; Single cell capture; Targeted sequencing; Whole genome amplification

Indexed keywords

CD45 ANTIGEN; CD56 ANTIGEN; GANGLIOSIDE GD2;

ARTICLE; BONE MARROW; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LEUKOCYTE; NEUROBLASTOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SHORT TANDEM REPEAT;

EID: 84904650287     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00201     Document Type: Article

References (52)

1. Nguyen, D.X., Bos, P.D., and Massague, J. (2009). Metastasis: from dissemination to organ- specific colonization. Nat Rev Cancer 9, 274-284. doi: 10.1038/nrc2622.
2. Kuukasjarvi, T., Karhu, R., Tanner, M., Kahkonen, M., Schaffer, A., Nupponen, N., et al. (1997). Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57, 1597-1604.
3. Stoecklein, N.H., Hosch, S.B., Bezler, M., Stern, F., Hartmann, C.H., Vay, C., et al. (2008). Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13, 441-453. doi: 10.1016/j.ccr.2008.04.005.
4. Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nat Rev Cancer 9, 302-312. doi: 10.1038/nrc2627.
5. Clark, J., Attard, G., Jhavar, S., Flohr, P., Reid, A., De-Bono, J., et al. (2008). Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 27, 1993-2003. doi: 10.1038/sj.onc.1210843.
6. Yu, M., Bardia, A., Wittner, B.S., Stott, S.L., Smas, M.E., Ting, D.T., et al. (2013). Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584. doi: 10.1126/science. 1228522.
7. Maley, C.C., Galipeau, P.C., Finley, J.C., Wongsurawat, V.J., Li, X., Sanchez, C.A., et al. (2006). Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38, 468-473. doi: 10.1038/ng1768.
8. Campbell, P.J., Yachida, S., Mudie, L.J., Stephens, P.J., Pleasance, E.D., Stebbings, L.A., et al. (2010). The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113. doi: 10.1038/nature09460.
9. Pantel, K., Brakenhoff, R.H., and Brandt, B. (2008). Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8, 329-340. doi: 10.1038/nrc2375.
10. Klein, C.A., Blankenstein, T.J., Schmidt-Kittler, O., Petronio, M., Polzer, B., Stoecklein, N.H., et al. (2002). Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360, 683-689. doi: 10.1016/S0140-6736(02)09838-0.
11. De Giorgi, U., Valero, V., Rohren, E., Dawood, S., Ueno, N.T., Miller, M.C., et al. (2009). Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol27, 3303-3311. doi: 10.1200/JCO.2008.19.4423.
12. Anderson, K., Lutz, C., Van Delft, F.W., Bateman, C.M., Guo, Y., Colman, S.M., et al. (2011). Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469, 356-361. doi: 10.1038/nature09650.
13. Park, S.Y., Gonen, M., Kim, H.J., Michor, F., and Polyak, K. (2010). Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. JClinInvest 120, 636-644. doi: 10.1172/JCI40724.
14. Cristofanilli, M., Budd, G.T., Ellis, M.J., Stopeck, A., Matera, J., Miller, M.C., et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N EnglJMed351, 781-791. doi: 10.1056/NEJMoa040766.
15. Braun, S., Vogl, F.D., Naume, B., Janni, W., Osborne, M.P., Coombes, R.C., et al. (2005). A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353, 793-802. doi: 10.1056/NEJMoa050434.
16. Cohen, S.J., Punt, C.J., Iannotti, N., Saidman, B.H., Sabbath, K.D., Gabrail, N.Y., et al. (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26, 3213-3221. doi: 10.1200/JCO.2007.15.8923.
17. De Bono, J.S., Scher, H.I., Montgomery, R.B., Parker, C., Miller, M.C., Tissing, H., et al. (2008). Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14, 6302-6309. doi: 10.1158/1078- 0432.CCR-08-0872.
18. Fabbri, F., Carloni, S., Zoli, W., Ulivi, P., Gallerani, G., Fici, P., et al. (2013). Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett 335, 225-231. doi: 10.1016/j.canlet.2013.02.015.
19. Peeters, D.J., De Laere, B., Van Den Eynden, G.G., Van Laere, S.J., Rothe, F., Ignatiadis, M., et al. (2013). Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. Br J Cancer 108, 1358-1367. doi: 10.1038/bjc.2013.92.
20. Borgatti, M., Altomare, L., Abonnec, M., Fabbri, E., Manaresi, N., Medoro, G., et al. (2005). Dielectrophoresis-based 'Lab-on-a-chip' devices for programmable binding of microspheres to target cells. IntJ Oncol 27, 1559-1566.
21. Borgatti, M., Altomare, L., Baruffa, M., Fabbri, E., Breveglieri, G., Feriotto, G., et al. (2005). Separation of white blood cells from erythrocytes on a dielectrophoresis (DEP) based 'Lab-on-a-chip' device. IntJMolMed 15, 913-920.
22. Fuchs, A.B., Romani, A., Freida, D., Medoro, G., Abonnenc, M., Altomare, L., et al. (2006). Electronic sorting and recovery of single live cells from microlitre sized samples. Lab Chip 6, 121-126. doi: 10.1039/b505884h.
23. Maris, J.M. (2010). Recent advances in neuroblastoma. NEnglJMed362, 2202-2211.
24. Seeger, R.C., Reynolds, C.P., Gallego, R., Stram, D.O., Gerbing, R.B., and Matthay, K.K. (2000). Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study. J Clin Oncol 18, 4067-4076.
25. Smith, M.A., Seibel, N.L., Altekruse, S.F., Ries, L.A., Melbert, D.L., O'leary, M., et al. (2010). Outcomes for children and adolescents with cancer: challenges for the twenty- first century. J Clin Oncol 28, 2625-2634. doi: 10.1200/JCO.2009.27.0421.
26. Burchill, S.A., Lewis, I.J., Abrams, K.R., Riley, R., Imeson, J., Pearson, A.D., et al. (2001). Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol 19, 1795-1801.
27. Riley, R.D., Heney, D., Jones, D.R., Sutton, A.J., Lambert, P.C., Abrams, K.R., et al. (2004). A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 10, 4-12.
28. Corrias, M.V., Haupt, R., Carlini, B., Parodi, S., Rivabella, L., Garaventa, A., et al. (2006). Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients. Clin Cancer Res 12, 5680-5685. doi: 10.1158/1078-0432.CCR-06-0740.
29. Stutterheim, J., Gerritsen, A., Zappeij-Kannegieter, L., Kleijn, I., Dee, R., Hooft, L., et al. (2008). PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma. J Clin Oncol26, 5443-5449. doi: 10.1200/JCO.2007.13.6531.
30. eiske, K., Burchill, S.A., Cheung, I.Y., Hiyama, E., Seeger, R.C., Cohn, S.L., et al. (2009). Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force. Br J Cancer 100, 1627-1637. doi: 10.1038/sj.bjc.6605029.
31. Mosse, Y.P., Lim, M.S., Voss, S.D., Wilner, K., Ruffner, K., Laliberte, J., et al. (2013). Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol 14, 472-480. doi: 10.1016/S1470-2045(13)70095-0.
32. Yu, A.L., Gilman, A.L., Ozkaynak, M.F., London, W.B., Kreissman, S.G., Chen, H.X., et al. (2010). Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. NEnglJMed363, 1324-1334. doi: 10.1056/NEJMoa0911123.
33. Ferreira-Facio, C.S., Milito, C., Botafogo, V., Fontana, M., Thiago, L.S., Oliveira, E., et al. (2013). Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer. PLoS One 8, e55534. doi: 10.1371/journal.pone.0055534.
34. Sariola, H., Terava, H., Rapola, J., and Saarinen, U.M. (1991). Cell-surface ganglioside GD2 in the immunohistochemical detection and differential diagnosis of neuroblastoma. Am J Clin Pathol 96, 248-252.
35. Cooper, M.A., Fehniger, T.A., and Caligiuri, M.A. (2001). The biology of human natural killer-cell subsets. Trends Immunol 22, 633-640.
36. Gross, H.J., Verwer, B., Houck, D., Hoffman, R.A., and Recktenwald, D. (1995). Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). Proc NatlAcadSci USA 92, 537-541.
37. Bajaj, S., Welsh, J.B., Leif, R.C., and Price, J.H. (2000). Ultra-rare-event detection performance of a custom scanning cytometer on a model preparation of fetal nRBCs. Cytometry 39, 285-294.
38. Gupta, V., Jafferji, I., Garza, M., Melnikova, V.O., Hasegawa, D.K., Pethig, R., et al. (2012). ApoStream(), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood. Biomicrofluidics 6, 24133. doi: 10.1063/1.4731647.
39. Bresler, S.C., Wood, A.C., Haglund, E.A., Courtright, J., Belcastro, L.T., Plegaria, J.S., et al. (2011). Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Sci TranslMed3, 108ra114. doi: 10.1126/scitranslmed.3002950.
40. Zhang, L., Ridgway, L.D., Wetzel, M.D., Ngo, J., Yin, W., Kumar, D., et al. (2013). The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci TranslMed5, 180ra148. doi: 10.1126/scitranslmed.3005109.
41. Breitenbuecher, F., Hoffarth, S., Worm, K., Cortes-Incio, D., Gauler, T.C., Kohler, J., et al. (2014). Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients. PLoS One 9, e85350. doi: 10.1371/journal.pone.0085350.
42. Issadore, D., Chung, J., Shao, H., Liong, M., Ghazani, A.A., Castro, C.M., et al. (2012). Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci TranslMed4, 141ra192. doi: 10.1126/scitranslmed.3003747.
43. Ahmed, M., Goldgur, Y., Hu, J., Guo, H.F., and Cheung, N.K. (2013). In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors. PLoS One 8, e63359. doi: 10.1371/journal.pone.0063359.
44. Zhan, J., Han, Q., and Wang, K. (2013). Development of antibody therapeutics for small cell lung cancer. Expert Opin Investig Drugs 22, 235-244. doi: 10.1517/13543784.2013.750293.
45. Dolezel, J., Bartos, J., Voglmayr, H., and Greilhuber, J. (2003). Nuclear DNA content and genome size of trout and human. Cytometry A 51, 127-128; author reply 129. doi: 10.1002/cyto.a. 10013.
46. Hou, Y., Song, L., Zhu, P., Zhang, B., Tao, Y., Xu, X., et al. (2012). Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148, 873-885. doi: 10.1016/j.cell.2012.02.028.
47. Xu, X., Hou, Y., Yin, X., Bao, L., Tang, A., Song, L., et al. (2012). Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148, 886-895. doi: 10.1016/j.cell.2012.02.025.
48. Magbanua, M.J., Sosa, E.V., Roy, R., Eisenbud, L.E., Scott, J.H., Olshen, A., et al. (2013). Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res 73, 30-40. doi: 10.1158/0008-5472.CAN-11-3017.
49. Sasaki, T., Okuda, K., Zheng, W., Butrynski, J., Capelletti, M., Wang, L., et al. (2010). The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers. Cancer Res 70, 10038-10043. doi: 10.1158/0008- 5472.CAN-10-2956.
50. Treff, N.R., Su, J., Tao, X., Northrop, L.E., and Scott, R.T., Jr. (2011). Single-cell whole- genome amplification technique impacts the accuracy of SNP microarray-based genotyping and copy number analyses. Mol Hum Reprod 17, 335-343. doi: 10.1093/molehr/gaq103.
51. De Giorgi, U., Cohen, E.N., Gao, H., Mego, M., Lee, B.N., Lodhi, A., et al. (2011). Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer- initiating cells in bone marrow. Cancer Biol Ther 11, 812-815.
52. Zong, C., Lu, S., Chapman, A.R., and Xie, X.S. (2012). Genome-wide detection of single- nucleotide and copy-number variations of a single human cell. Science 338, 1622-1626. doi: 10.1126/science. 1229164.